---
figid: PMC9688488__cells-11-03552-g004
figtitle: HIF-1A Regulates Bone Homeostasis and Angiogenesis, Participating in the
  Occurrence of Bone Metabolic Diseases
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9688488
filename: cells-11-03552-g004.jpg
figlink: /pmc/articles/PMC9688488/figure/cells-11-03552-f004/
number: F4
caption: HIF-1α couples angiogenesis and osteogenesis. HIF-1α/VEGF and Notch signal
  pathways are pivotal in coupling Type H vessels angiogenesis and BMSCs osteogenic
  differentiation, in which matrix metalloproteinase-2 inhibitor 1 (MMP2-I1) and Osteostatin
  (OST) play a positive regulatory role. In addition, the HIF-1α/VEGF pathway also
  promotes alkaline phosphatase (ALP) and Osterix, inhibits peroxisome proliferators-activated
  receptors (PPARγ), promotes BMSCs osteogenic differentiation, and participates in
  the occurrence of osteoporosis, osteonecrosis, and bone defect.
papertitle: HIF-1α Regulates Bone Homeostasis and Angiogenesis, Participating in the
  Occurrence of Bone Metabolic Diseases.
reftext: Wei Chen, et al. Cells. 2022 Nov;11(22):3552.
year: '2022'
doi: 10.3390/cells11223552
journal_title: Cells
journal_nlm_ta: Cells
publisher_name: MDPI
keywords: hypoxia-inducible factor-1α | bone homeostasis | bone metabolic diseases
  | osteogenesis | angiogenesis | non-coding RNA | biomaterials | trace elements
automl_pathway: 0.963533
figid_alias: PMC9688488__F4
figtype: Figure
redirect_from: /figures/PMC9688488__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9688488__cells-11-03552-g004.html
  '@type': Dataset
  description: HIF-1α couples angiogenesis and osteogenesis. HIF-1α/VEGF and Notch
    signal pathways are pivotal in coupling Type H vessels angiogenesis and BMSCs
    osteogenic differentiation, in which matrix metalloproteinase-2 inhibitor 1 (MMP2-I1)
    and Osteostatin (OST) play a positive regulatory role. In addition, the HIF-1α/VEGF
    pathway also promotes alkaline phosphatase (ALP) and Osterix, inhibits peroxisome
    proliferators-activated receptors (PPARγ), promotes BMSCs osteogenic differentiation,
    and participates in the occurrence of osteoporosis, osteonecrosis, and bone defect.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TIMP3
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - ANGPT2
  - VPS51
  - ANGPT1
  - TM7SF2
  - MIR210
  - SP7
  - ALPP
  - ATHS
  - SLPI
  - CCL27
  - ATRNL1
  - PDLIM3
  - NAT10
  - ASRGL1
  - RUNX2
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - MMP9
  - MMP3
  - MMP8
  - ILF3
  - MMP7
  - MMP2
  - MMP10
  - MMP11
  - DDOST
  - MCF2L
  - PECAM1
  - EMCN
  - TGFB1
  - TGFB2
  - TGFB3
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MTOR
  - tetramethylpyrazine
  - DFO
---
